JAZZ

247.72

1.45% 3.55

Dopo l'orario di chiusura: 249.00 1.28 +0.52%

Jazz Pharmaceuticals Plc (JAZZ)

Panoramica Notizia Cronologia dei prezzi Catena di opzioni Financials Forum Previsione

Precedente Chiudi:

$244.17

Aprire:

$244.415

Volume 24 ore:

919.61K

Relative Volume:

0.98

Capitalizzazione di mercato:

$15.56B

Reddito:

$4.44B

Utile/perdita netta:

$29.49M

Rapporto P/E:

-13,463.04

EPS:

-0.0184

Flusso di cassa netto:

$1.19B

1 W Prestazione:

+2.80%

1M Prestazione:

+3.84%

6M Prestazione:

+46.26%

1 anno Prestazione:

+130.22%

Intervallo 1D:

$238.92

$249.64

Intervallo di 1 settimana:

$234.36

$249.64

Portata 52W:

$105.00

$249.64

Jazz Pharmaceuticals Plc Stock (JAZZ) Company Profile

Nome

Jazz Pharmaceuticals Plc

Settore

Healthcare (1094)

Industria

Biotechnology (615)

Telefono

353-1-634-7800

Indirizzo

FIFTH FLOOR, WATERLOO EXCHANGE, DUBLIN

Dipendente

2,890

Cinguettio

@jazzpharma

Prossima data di guadagno

2026-08-04

Ultimi documenti SEC

JAZZ's Discussions on Twitter

Compare JAZZ vs VRTX, REGN, ARGX, ALNY, RVMD

Azioni	Prezzo	Cap. di mercato	Reddito	Reddito netto	Flusso di cassa	EPS
JAZZ Jazz Pharmaceuticals Plc	247.72	15.34B	4.44B	29.49M	1.19B	-0.0184
VRTX Vertex Pharmaceuticals Inc	522.25	134.41B	12.34B	4.34B	3.71B	16.87
REGN Regeneron Pharmaceuticals Inc	676.23	68.13B	14.92B	4.42B	3.79B	41.04
ARGX Argen X Se Adr	919.93	57.01B	4.16B	1.29B	734.26M	19.58
ALNY Alnylam Pharmaceuticals Inc	321.50	41.79B	4.29B	577.22M	641.34M	4.2086
RVMD Revolution Medicines Inc	190.46	40.39B	742.00K	-1.37B	-1.07B	-7.0731

Jazz Pharmaceuticals Plc Stock (JAZZ) Upgrades & Downgrades

Data	Azione	Analista	Modifica della valutazione
2026-04-10	Ripresa	Raymond James	Outperform
2026-02-27	Iniziato	Barclays	Overweight
2025-11-24	Downgrade	UBS	Buy → Neutral
2025-07-15	Iniziato	Deutsche Bank	Buy
2025-03-07	Aggiornamento	UBS	Neutral → Buy
2025-02-26	Downgrade	Cantor Fitzgerald	Overweight → Neutral
2025-02-13	Aggiornamento	Wells Fargo	Equal Weight → Overweight
2024-12-12	Aggiornamento	Morgan Stanley	Equal-Weight → Overweight
2024-06-05	Iniziato	Goldman	Buy
2024-01-03	Iniziato	Robert W. Baird	Outperform
2023-11-27	Downgrade	UBS	Buy → Neutral
2023-09-29	Iniziato	Raymond James	Mkt Perform
2023-06-12	Ripresa	Wells Fargo	Equal Weight
2022-12-09	Aggiornamento	Goldman	Neutral → Buy
2022-06-14	Iniziato	UBS	Buy
2022-04-06	Downgrade	Goldman	Buy → Neutral
2021-11-19	Ripresa	Goldman	Buy
2021-10-07	Ripresa	Jefferies	Buy
2021-10-05	Iniziato	Citigroup	Buy
2021-09-23	Iniziato	Needham	Buy
2021-05-19	Ripresa	JP Morgan	Overweight
2021-04-07	Ripresa	RBC Capital Mkts	Outperform
2021-02-05	Reiterato	H.C. Wainwright	Buy
2021-02-03	Aggiornamento	Piper Sandler	Neutral → Overweight
2021-01-29	Downgrade	Morgan Stanley	Overweight → Equal-Weight
2020-12-16	Iniziato	UBS	Buy
2020-11-03	Reiterato	H.C. Wainwright	Buy
2020-10-09	Reiterato	H.C. Wainwright	Buy
2020-09-14	Downgrade	Goldman	Neutral → Sell
2020-09-14	Ripresa	JP Morgan	Overweight
2020-08-06	Aggiornamento	Morgan Stanley	Equal-Weight → Overweight
2020-07-28	Aggiornamento	Wolfe Research	Peer Perform → Outperform
2020-07-23	Aggiornamento	H.C. Wainwright	Neutral → Buy
2020-04-06	Iniziato	Jefferies	Buy
2020-03-12	Aggiornamento	Bernstein	Mkt Perform → Outperform
2020-01-08	Iniziato	Goldman	Neutral
2019-08-21	Downgrade	Piper Jaffray	Overweight → Neutral
2019-06-11	Iniziato	Barclays	Overweight
2019-03-20	Iniziato	SunTrust	Buy
2018-12-14	Iniziato	Wolfe Research	Peer Perform
2018-11-08	Reiterato	B. Riley FBR	Buy
2018-08-08	Reiterato	Stifel	Buy
2018-07-11	Downgrade	Morgan Stanley	Overweight → Equal-Weight
2018-03-23	Reiterato	H.C. Wainwright	Neutral
2018-03-19	Aggiornamento	Morgan Stanley	Equal-Weight → Overweight

Mostra tutto

Jazz Pharmaceuticals Plc Borsa (JAZZ) Ultime notizie

09:24 AM

JAZZ Maintains Rating by Truist Securities -- Price Target Lowered to $254 - GuruFocus

09:24 AM

Jul 06, 2026

Sleep Apnea Pipeline 2026: Therapies, MOA Insights, and Key Clinical Trial Updates by DelveInsight | Apnimed, Eli Lilly, Incannex Healthcare, Axsome Therapeutics, Jazz Pharma, Bioprojet - Barchart.com

Jul 06, 2026

Jazz Pharmaceuticals Holds Steady Near Resistance as Volume Patterns Signal CautionQuality Factor - dars.gov.et

Jul 06, 2026

Jazz Pharmaceuticals PLC at TD Cowen Oncology Innovation Summit (Virtual) Transcript - GuruFocus

Jul 06, 2026

Jul 03, 2026

JAZZJazz Pharmaceuticals plc Options - Finviz

Jul 03, 2026

Jul 02, 2026

Jazz Pharmaceuticals (JAZZ) Breakout Keeps Valuation In Focus Following Zepzelca Setback And Ziihera Hopes - simplywall.st

Jul 02, 2026

Jazz Pharmaceuticals (JAZZ) EVP reports RSU tax withholding and retains 47,911 shares - Stock Titan

Jul 02, 2026

Jazz Pharmaceuticals (JAZZ) CEO shares withheld to cover RSU tax obligations - Stock Titan

Jul 02, 2026

Jazz Pharmaceuticals (JAZZ) insider RSU tax withholding detailed - Stock Titan

Jul 02, 2026

Jazz Pharmaceuticals (JAZZ) CFO reports 3,343-share tax withholding - Stock Titan

Jul 02, 2026

Jazz Pharmaceuticals (JAZZ) Price Forecast: Will Breakout Confirm Higher Highs? - FXEmpire

Jul 02, 2026

Jazz Pharmaceuticals stock hits all-time high at 243.39 USD - Investing.com

Jul 02, 2026

Jazz Pharmaceuticals stock hits all-time high at 243.39 USD By Investing.com - Investing.com UK

Jul 02, 2026

Jul 01, 2026

Form 144 Jazz Pharmaceuticals Plc For: 1 July By Investing.com - Investing.com Nigeria

Jul 01, 2026

Bruce Cozadd files Form 144 to sell shares — Jazz Pharmaceuticals (NASDAQ: JAZZ) - Stock Titan

Jul 01, 2026

Jun 30, 2026

Enterprise value to revenue forward of Jazz Pharmaceuticals plc – NASDAQ:JAZZ - TradingView

Jun 30, 2026

Price to earnings forward of Jazz Pharmaceuticals plc – NASDAQ:JAZZ - TradingView

Jun 30, 2026

Price to book forward of Jazz Pharmaceuticals plc – NASDAQ:JAZZ - TradingView

Jun 30, 2026

Is Jazz Pharmaceuticals (JAZZ) Using AbCellera Deal to Quietly Redefine Its Oncology Strategy? - simplywall.st

Jun 30, 2026

3 Overrated Stocks Walking a Fine Line - Yahoo Finance UK

Jun 30, 2026

Price to sales forward of Jazz Pharmaceuticals plc – NASDAQ:JAZZ - TradingView

Jun 30, 2026

Jun 29, 2026

Is HRMY Stock Worth Buying With Neutral Signals and Cheap Valuation? - TradingView

Jun 29, 2026

Jazz Pharmaceuticals' Lung Cancer Drug Setback in Late-Stage Trials: Here's Why the Stock Impact May Be More Limited Than It Looks - AOL.com

Jun 29, 2026

Jun 27, 2026

Erica Jefferson Joins Jazz Pharmaceuticals as Chief Communications Officer - hrtoday.in

Jun 27, 2026

Jun 26, 2026

JAZZ Forecast — Price Target — Prediction for 2027 - TradingView

Jun 26, 2026

Jazz Pharmaceuticals' lung cancer drug setback in late-stage trials: Here's why the stock impact may be more limited than it looks - MSN

Jun 26, 2026

Jazz Pharma announces late-stage trial setback for lung cancer therapy - MSN

Jun 26, 2026

Jazz Pharmaceuticals Public Limited Company Actuals & Estimates (NASDAQ:JAZZ) - TradingView

Jun 26, 2026

Jazz Pharmaceuticals: Why It's Time To Cash Out (Rating Downgrade) (NASDAQ:JAZZ) - Seeking Alpha

Jun 26, 2026

Jun 25, 2026

Jazz Pharmaceuticals (JAZZ) Reframed Zepzelca Growth, Is The Stock Still Below Fair Value? - simplywall.st

Jun 25, 2026

Strong Leaders Build Strong Teamsand Strong Teams Change Patients’ LivesJazz Pharmaceuticals - Oncodaily

Jun 25, 2026

Jazz Pharmaceuticals PLC (HAM:J7Z) Stock Price, Trades & News - GuruFocus

Jun 25, 2026

Jun 24, 2026

Jazz Pharmaceuticals (JAZZ) Stock Gets Fair Value Boost As Ziihera Views Split Analysts - Yahoo Finance

Jun 24, 2026

Jun 23, 2026

Jazz Pharmaceuticals and AbCellera Biologics Inc. (ABCL) Announce Collaboration - Yahoo Finance UK

Jun 23, 2026

Will Zepzelca’s Failed LAGOON Trial in Second-Line SCLC Change Jazz Pharmaceuticals' (JAZZ) Narrative? - simplywall.st

Jun 23, 2026

Jun 22, 2026

JAZZ’s Zepzelca fails to meet primary goal in lung cancer study - MSN

Jun 22, 2026

Investor Outlook: Jazz Pharmaceuticals Plc (JAZZ) And Its 14.40% Potential Upside - DirectorsTalk Interviews

Jun 22, 2026